Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
PALO ALTO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq:SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today issued a letter from Jaisim Shah, its Chief Executive Officer and President, to its stockholders highlighting the Company’s accomplishments in 2023 and its forward outlook for 2024.
Related news for (SCLX)
- MoBot’s Stock Market Highlights – 03/03/25 04:00 PM
- Today’s Top Performers: MoBot’s Market Review 03/03/25 03:00 PM
- Denali Capital Acquisition Corp and Scilex Holding’s Semnur Pharmaceuticals Sign LOI for Proposed Business Combination
- Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information